NEW YORK (GenomeWeb News) – The Japan Patent Office has licensed Xennex’s genomic database for use in reviewing patent applications, the Cambridge, Mass.-based company said Monday.
Under the license agreement, the JPO will use the Xennex GeneCards database, which includes mined genomic, proteomic, and transcriptomics information, and focuses on functional genomics and disease, to conduct prior art research to determine if an invention can be patented.
The JPO includes the departments of General Affairs, Examination, and Appeals, which together grant patent rights, draft plans for IP policies, manage international exchange and cooperation, conduct IP review, and disseminate IP information.
In addition, Xennex said that Bioscene Informatics will exclusively distribute GeneCards in Japan.
Financial terms of the agreements were not released.